Work

312 Low Dose Double Epigenetic Therapy Improves Immunotherapy Response and Prolongs Survival in Pancreatic Cancer.

Year: 2024

Type: article

Source: Gastroenterology

DOI: 10.1016/s0016-5085(24)00651-6

Authors: Arturo Orlacchio, Stephen Muzyka, Jiufeng Li, Diane M. Simeone, Tamas Gonda

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4396637919

FWCI: 0.172

Cites:

Cited by: 1

Related to: 10